Effect of dimebon on cognition, activities of daily living, behaviour, and global function
in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study
The Lancet, Volume 372, Issue 9634, 19 July 2008-25 July 2008, Pages 207-215
Rachelle S Doody, Svetlana I Gavrilova, Mary Sano, Ronald G Thomas, Paul S Aisen, Sergey O Bachurin, Lynn Seely, David Hung and on behalf of the dimebon investigators
Geen opmerkingen:
Een reactie posten